PBF Energy enters its Q1 2026 earnings day with shorts unwinding sharply and options sentiment flipping to its most bullish reading of the past year — a rare alignment that stands in direct contrast to a Street that remains broadly cautious on the stock.
The biggest move this week was in short positioning. Short interest has dropped 19% over the past month and 6.5% over just the past week, settling at 10.7% of the free float. That's a meaningful retreat from the ~18% level seen in late March, when shorts held nearly 21.5 million shares. The unwind accelerated after April 22. Borrow conditions confirm the story: cost to borrow has collapsed to just 0.23% from above 2% at the end of March, a near-90% monthly decline. Availability is wide open — borrow pressure here is essentially non-existent. Shorts are not being squeezed out; they are leaving voluntarily. That distinction matters.
Options tell an even sharper story. The put/call ratio has dropped to 0.43 — the lowest reading of the past 52 weeks and more than two standard deviations below its 20-day mean of 0.67. For context, PBF's PCR was running above 0.75 throughout March and most of April. The shift is abrupt and pronounced. Options traders are positioned for upside at a degree rarely seen in this name. The stock itself is up 6.6% on the week and 4.3% on the day alone, trading at $43.13. That said, it remains 15.8% below where it was a month ago, so the week's bounce follows a significant drawdown. Refining peers moved similarly — surged 18.4% on the week and added 10.9%, suggesting a broad sector re-rating rather than a PBF-specific catalyst.
The Street, however, has not caught up with the options market's optimism. Most analysts remain on the sidelines or bearish. This week, TD Cowen's Jason Gabelman cut his price target to $36 from $41 while holding a Sell rating. Morgan Stanley raised its target to $34 from $27 — but kept an Underweight. The mean analyst target is $42, essentially at the current price of $43, implying no return potential on consensus numbers. Only Piper Sandler carries an Overweight, with a $42 target. The valuation picture offers some support: the P/E is running at 8x, P/B at 0.84x, and EV/EBITDA at roughly 4.2x — all reflecting the market's deep skepticism about refining margins holding up. EPS momentum, however, ranks in the 91st percentile on a 30-day basis and 94th percentile over 90 days, suggesting forward estimates are being revised higher even as the stock and its rating consensus lag. That divergence between estimate momentum and analyst ratings is the central tension for the bull case.
On insider activity, the signal is one-sided and not encouraging. Carlos Slim Helú, the 10% shareholder, sold around 200,000 shares in early April at prices near $46-$47 — roughly $9.3 million in total proceeds, all after the stock had already started to decline. Chairman Thomas Nimbley sold 50,000 shares on March 31 near $50.62, and SVP James Fedena executed multiple tranches totalling roughly 77,000 shares over the same session. The 90-day net value sold is approximately $205 million. There has been no insider buying. Control Empresarial de Capitales — the Slim family vehicle — also reduced its stake by nearly 11.6 million shares to 16.5% of the company as of April 7. That is a substantial reduction from a concentrated holder, and it has weighed on sentiment through much of the month.
Q1 results are due today, April 30. The one recent earnings data point in the snapshot — April 28 — showed a 5.8% single-day move upward, which may have pulled forward some of this week's price action. With shorts retreating, options leaning hard toward calls, and EPS estimates trending higher, the next print sets up as a test of whether the fundamental picture actually justifies the optimism baked into this week's positioning shift — or whether the Street's cautious consensus proves better calibrated than the options market.
See the live data behind this article on ORTEX.
Open PBF on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
